| |
| |
|
| Insider
Information: |
Tananbaum James B. |
| Relationship: |
10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
1,064,512 |
|
|
Indirect Shares
|
33,413,451 |
|
|
| Direct
Value |
$19,999,397 |
|
|
|
Indirect Value
|
$436,713,163 |
|
|
| Total
Shares |
34,477,963 |
|
|
| Total
Value |
$456,712,560 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
9
|
1
|
|
Stock
price went up :
|
8
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
8.0
|
-1.0
|
| Percentage
Gain/Loss : |
 36.0%
|
 -23.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aimmune Therapeutics, Inc. |
AIMT |
10% Owner |
2015-08-11 |
0 |
2016-08-18 |
4,902,920 |
Premium* |
|
|
Aerie Pharmaceuticals Inc |
AERI |
10% Owner |
2016-07-22 |
0 |
2020-02-27 |
1,229,633 |
Premium* |
|
|
10x Genomics, Inc. |
TXG |
10% Owner |
2019-09-12 |
0 |
2020-05-13 |
2,677,383 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
Director |
2020-08-14 |
441,500 |
2021-02-05 |
3,370,250 |
Premium* |
|
|
Kinnate Biopharma Inc. |
KNTE |
|
2020-12-07 |
0 |
2024-04-03 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
|
0 |
2021-11-01 |
4,665,553 |
Premium* |
|
|
Pardes Biosciences Ord Shs |
PRDS |
Director, 10% Owner |
2021-02-19 |
602,500 |
2023-04-05 |
13,583,762 |
Premium* |
|
|
Highcape Capital Acquisition Corp. |
QSI |
Director |
2021-06-11 |
20,512 |
2021-06-10 |
1,598,125 |
Premium* |
|
|
Theseus Pharmaceuticals, Inc. |
THRX |
10% Owner |
|
0 |
2023-07-17 |
1,385,825 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AIMT |
Aimmune Therapeutics, Inc... |
10% Owner |
– – • |
2015-08-11 |
4 |
A |
$0.00 |
$0 |
I/I |
3,775,400 |
3,775,400 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
10% Owner |
– – • |
2020-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
2,130,804 |
683,725 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
10% Owner |
– – • |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
I/I |
366,895 |
125,276 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
10% Owner |
– – • |
2020-03-24 |
4 |
A |
$0.00 |
$0 |
I/I |
2,170,619 |
2,358,119 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
10% Owner |
– – • |
2020-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
332,650 |
235,125 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
10% Owner |
– – • |
2020-04-14 |
4 |
A |
$0.00 |
$0 |
I/I |
1,500,000 |
1,500,000 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
10% Owner |
– – • |
2020-04-22 |
4 |
A |
$0.00 |
$0 |
I/I |
270,842 |
327,383 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
10% Owner |
– – • |
2020-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,000,000 |
1,869,802 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
10% Owner |
– – • |
2020-05-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,000,000 |
3,000,000 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
10% Owner |
– – • |
2020-05-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,930,198 |
4,300,000 |
0 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
|
• • • |
2020-12-07 |
4 |
A |
$0.00 |
$0 |
I/I |
9,838,311 |
291,667 |
0 |
- |
|
| IRON |
Disc Medicine, Inc |
Director |
– • – |
2021-02-05 |
4 |
A |
$10.00 |
$15,000,000 |
I/I |
1,500,000 |
1,500,000 |
0 |
- |
|
| IRON |
Disc Medicine, Inc |
Director |
– • – |
2021-02-05 |
4 |
A |
$0.00 |
$0 |
I/I |
2,928,750 |
2,928,750 |
0 |
- |
|
| QSI |
Highcape Capital Acquisit... |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$25,000,696 |
I/I |
8,403,805 |
1,598,125 |
0 |
- |
|
| QSI |
Highcape Capital Acquisit... |
Director |
– • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
20,512 |
20,512 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
– – • |
2021-11-01 |
4 |
A |
$0.00 |
$0 |
I/I |
8,276 |
8,276 |
0 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
Director |
– • • |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
I/I |
1,100,000 |
1,975,001 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
10% Owner |
– – • |
2015-08-11 |
4 |
B |
$16.00 |
$10,349,199 |
I/I |
642,035 |
329,535 |
1.5 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
10% Owner |
– – • |
2015-08-24 |
4 |
B |
$19.65 |
$500,900 |
I/I |
25,485 |
355,020 |
1.5 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2016-07-22 |
4 |
B |
$17.50 |
$4,375,000 |
I/I |
250,000 |
1,697,884 |
1.5 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-08-12 |
4 |
B |
$24.43 |
$4,630,829 |
I/I |
189,555 |
1,060,000 |
1.5 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-08-13 |
4 |
B |
$24.92 |
$6,337,342 |
I/I |
250,000 |
1,310,000 |
1.5 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-08-14 |
4 |
B |
$23.73 |
$2,373,000 |
I/I |
100,000 |
2,050,477 |
1.5 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-08-16 |
4 |
B |
$24.23 |
$2,423,000 |
I/I |
100,000 |
2,150,477 |
1.5 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-08-19 |
4 |
B |
$23.34 |
$89,789 |
I/I |
3,847 |
2,154,324 |
1.5 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
